VIVUS Announces Favorable Markman Ruling in Qsymia(R) Patent Litigation

MOUNTAIN VIEW, CA--(Healthcare Sales & Marketing Network) - VIVUS, Inc. (VVUS) today announced that the United States District Court for the District of New Jersey has issued a claim construction (Markman) ruling governing patent litigation brought by VIVU... Biopharmaceuticals, Generics, LitigationVIVUS, Actavis Laboratories, Teva Pharmaceutical, Qsymia, phentermine
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news